Literature DB >> 34801166

Peri-adolescent exposure to (meth)amphetamine in animal models.

T J Phillips1, S J Aldrich2.   

Abstract

Experimentation with psychoactive drugs is often initiated in the peri-adolescent period, but knowledge of differences in the outcomes of peri-adolescent- vs adult-initiated exposure is incomplete. We consider the existing animal research in this area for (meth)amphetamines. Established for a number of phenotypes, is lower sensitivity of peri-adolescents than adults to acute effects of (meth)amphetamines, including neurotoxic effects of binge-level exposure. More variable are data for long-term consequences of peri-adolescent exposure on motivational and cognitive traits. Moreover, investigations often exclude an adult-initiated exposure group critical for answering questions about outcomes unique to peri-adolescent initiation. Despite this, it is clear from the animal research that (meth)amphetamine exposure during the peri-adolescent period, whether self- or other-administered, impacts brain motivational circuitry and cognitive function, and alters adult sensitivity to other drugs and natural rewards. Such consequences occurring in humans have the potential to predispose toward unfortunate and potentially disastrous family, social and livelihood outcomes.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; Amphetamine; Cognition; Methamphetamine; Motivation; Neurotoxicity; Reward; Social behavior

Mesh:

Substances:

Year:  2021        PMID: 34801166      PMCID: PMC9134876          DOI: 10.1016/bs.irn.2021.06.011

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   4.280


  104 in total

Review 1.  Consequences of adolescent use of alcohol and other drugs: Studies using rodent models.

Authors:  Linda Patia Spear
Journal:  Neurosci Biobehav Rev       Date:  2016-07-30       Impact factor: 8.989

Review 2.  AMPed-up adolescents: The role of age in the abuse of amphetamines and its consequences on cognition and prefrontal cortex development.

Authors:  Sara R Westbrook; Lauren K Carrica; Asia Banks; Joshua M Gulley
Journal:  Pharmacol Biochem Behav       Date:  2020-08-20       Impact factor: 3.533

3.  Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity.

Authors:  Jannine G Truong; Diana G Wilkins; Jakub Baudys; Dennis J Crouch; Kamisha L Johnson-Davis; James W Gibb; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2005-05-18       Impact factor: 4.030

4.  Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.

Authors:  Lisa M McFadden; Amanda J Hoonakker; Paula L Vieira-Brock; Kristen A Stout; Nicole M Sawada; Jonathan D Ellis; Scott C Allen; Elliot T Walters; Shannon M Nielsen; James W Gibb; Mario E Alburges; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  Synapse       Date:  2011-03-21       Impact factor: 2.562

5.  Persistent expression of methamphetamine-induced CTA in periadolescent rats.

Authors:  Steven B Harrod; Ryan T Lacy; Lauren E Ballina
Journal:  Pharmacol Biochem Behav       Date:  2010-07-23       Impact factor: 3.533

6.  Extended access self-administration of methamphetamine is associated with age- and sex-dependent differences in drug taking behavior and recognition memory in rats.

Authors:  Sara R Westbrook; Megan R Dwyer; Laura R Cortes; Joshua M Gulley
Journal:  Behav Brain Res       Date:  2020-05-08       Impact factor: 3.332

Review 7.  Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review.

Authors:  Thomas E Nordahl; Ruth Salo; Martin Leamon
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

8.  Extended access to cocaine self-administration enhances drug-primed reinstatement but not behavioral sensitization.

Authors:  Lori A Knackstedt; Peter W Kalivas
Journal:  J Pharmacol Exp Ther       Date:  2007-06-29       Impact factor: 4.030

9.  GluN1 and GluN2A NMDA Receptor Subunits Increase in the Hippocampus during Memory Consolidation in the Rat.

Authors:  Magali C Cercato; Cecilia A Vázquez; Edgar Kornisiuk; Alejandra I Aguirre; Natalia Colettis; Marina Snitcofsky; Diana A Jerusalinsky; María V Baez
Journal:  Front Behav Neurosci       Date:  2017-01-13       Impact factor: 3.558

Review 10.  Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity.

Authors:  Luca Franchini; Nicolò Carrano; Monica Di Luca; Fabrizio Gardoni
Journal:  Int J Mol Sci       Date:  2020-02-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.